Tariffs
Latest in Tariffs
US 100% Tariff on Branded Drugs: Implications and Carve-Outs
Starting October 1, 2025, the U.S. will levy a 100% tariff on imported branded/patented drugs, with an exemption for firms…
Is the H-1B Era Ending? The $100K Fee and Transfers Clarification
A Sept 19, 2025 presidential proclamation imposes a $100,000 fee on new H-1B petitions effective Sept 21; White House says…
US Pushes Market Reforms on India and Brazil Amid Tariff Pressure
The U.S. imposed heavy 2025 tariffs—50% on many Indian and Brazilian exports—and tightened de minimis rules to pressure both countries…
India-U.S. Talks Face Section 232 Tariffs, Casting Doubt on a Deal
The U.S. widened Section 232 probes into key sectors, including a planned 100% pharma tariff from October 2025, undermining India-U.S.…
Finance Ministry: H-1B Fee Shock Real, Yet Manageable for India
India says the U.S. one-time USD 100,000 H-1B fee risks IT export earnings and jobs but can be managed through…
JPMorgan Sees India Flourishing Despite U.S. Trade and Visa Hurdles
JPMorgan views U.S. tariffs and a $100,000 visa fee as short-term shocks, not derailers of India’s growth. Domestic demand, GST…
Why Make America Great Again Persists Despite U.S. Global Lead
The White House plan imposes a 10% baseline tariff, higher targeted duties including 100% on some Indian drugs, and a…
H-1B Surcharge: Indian IT Firms to Pass 30–70% to Clients
Effective September 21, 2025, a $100,000 one-time surcharge applies to new H-1B petitions for 12 months. Crisil forecasts a 10–20…